Following are the Top 5 companies based on their one-day percentage change within the 'Key Chinese Stocks listed in US' theme.Baozun Inc. (BZUN)BZUN is trading UP for the last 2 days, and it at trading at $3.07 with volume of 155,832 and a one day change of $0.01 (0.33%). Baozun Inc. has a 52-week low...
Roger Song from Jefferies issued a price target of $150.00 for NKTR on 2026-10-01 18:22:36.The adjusted...
Jefferies analyst issues BUY recommendation for NKTR on October 1, 2026 06:22PM ET. The previous analyst...
Citigroup analyst issues MARKET PERFORM recommendation for FHTX on October 1, 2026 06:45PM ET. The previous...
Laura Prendergast from Stifel Nicolaus issued a price target of $5.00 for FHTX on 2026-10-01 16:53:44.The...
Roger Song from Jefferies issued a price target of $150.00 for NKTR on 2026-10-01 18:22:36.The adjusted price target was set to $150.00.At the time of the announcement, NKTR was trading...
Laura Prendergast from Stifel Nicolaus issued a price target of $5.00 for FHTX on 2026-10-01 16:53:44.The adjusted price target was set to $5.00.At the time of the announcement, FHTX was...
from Evercore ISI issued a price target of $150.00 for BNY on 2026-10-01 11:45:04.The adjusted price target was set to $150.00.At the time of the announcement, BNY was trading at...
Mayank Mamtani from B.Riley Financial issued a price target of $83.00 for CUE on 2026-10-01 09:03:00.The adjusted price target was set to $83.00.At the time of the announcement, CUE was...
Josh Nichols from B.Riley Financial issued a price target of $27.00 for OOMA on 2026-09-30 16:08:00.The adjusted price target was set to $27.00.At the time of the announcement, OOMA was...
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
